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S34 Podium Presentations
least 2 in at least 1 knee. 13.6% had an osteophyte score of at
least 2 and 4.6% joint space narrowing of at least 2. Tibio-femoral
osteoarthritis was present in 35.9% of patients. The mean intake
of vitamin D was 3.17 micrograms a day, which is well below the
recommended daily intake. Vitamin D intake was negatively as-
sociated with tibia femoral K&L score (p=0.028) and osteophyte
score (p=0.013) but not tibio-femoral joint space score (p=0.28).
The correlations were stronger in females than males, although
the difference was not statistically significant. There were no
associations between vitamin D intake and patello-femoral joint
space score. There was no association between supplementary
vitamin D intake and any of the radiographic variables.
Conclusions: Low vitamin D intake is associated with an in-
crease prevelance of radiographic osteoarthritis and this is par-
ticularly driven by osteophytosis. There is no association with
patello-femoral disease. Further work exploring vitamin D intake
and osteoarthritis is recommended.
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A SNP LOCATED DOWNSTREAM OF BMP5 IS
ASSOCIATED WITH ALLELIC EXPRESSION IMBALANCE
AT THE GENE AND WITH PRIMARY OSTEOARTHRITIS
J. Loughlin, L. Southam, Z. Mustafa, B. Dowling, J. Wilkins,
S. Snelling, K. Chapman
University of Oxford, Oxford, United Kingdom
Purpose: We have previously observed that the bone morpho-
genetic protein 5 gene BMP5 demonstrates a high degree of
differential allelic expression (DAE) in articular cartilage chon-
drocytes, implying the presence of polymorphism within cis-
regulatory elements of the gene. Our hypothesis is that this
polymorphism confers OA susceptibility. The aim of this study
was to map the variants that correlate with DAE at BMP5 and to
then test their association with OA in a case-control cohort.
Methods: We genotyped 41 haplotype-tagging SNPs within a
416 kb interval encompassing and flanking BMP5 in 23 OA
patients for whom we had determined the allelic expression
profile. DAE status and SNP genotype were then correlated
using the nonparametric Mann-Whitney test. Overall levels of
BMP5 expression in chondrocytes were determined using real-
time (RT)-PCR. Association analysis was performed on a cohort
of 605 females with primary hip OA and 730 female controls, all
of UK Caucasian origin. Ethical approval was obtained from local
ethics committees.
Results: A SNP located 5kb downstream of BMP5 demonstrated
significant correlation with DAE status (P < 0.005). The minor
allele of the SNP was also correlated with an overall reduction in
BMP5 expression as assessed by RT-PCR (P = 0.03). Homozy-
gotes for the minor allele were significantly more prevalent in our
cases (5.5%) than our controls (2.1%) with a P-value of 0.002
and odds ratio of 2.7 (95% CI 1.5-5.1). A subsequent detailed
analysis of the HapMap revealed that the associated SNP is part
of an extended haplotype block up to 80kb in length.
Conclusions: We have generated both genetic and functional
data that support a role for downstream cis-acting regulatory
elements of BMP5 as OA susceptibility loci.
Research into Ageing and the Arthritis Research Campaign
supported this study.
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RISK PREDICTION OF KNEE OSTEOARTHRITIS USING
MULTIPLE GENES
A.M. Valdes1, G.L. Surdulescu1, M. Doherty2, T.D. Spector1
1St Thomas Hospital, London, United Kingdom, 2Academic
Rheumatology Unit, University of Nottingham, City Hospital,
Nottingham, United Kingdom
Purpose: Primary osteoarthritis (OA) is the most common cause
of joint disability in the developed world. A number of phenotypic
risk factors have been identified and genetic factors are also
major determinants of disease. The objective of this study was
to assess how much of the risk of knee OA could be predicted
by combinations of genetic polymorphisms associated in other
populations with hip and/or knee OA.
Methods: Genetic polymorphisms in OA candidate genes were
genotyped in 298 men and 305 women aged 50-86 diagnosed
with knee OA assessed clinically and radiographically, and in 300
male and 299 female age and ethnicity matched controls. 18 OA
candidate genes which had been previously reported to influence
knee or hip OA risk or both were studied: FRZB, COMP, COL2A1,
VDR, AACT, ADAM12, CILP, BMP2, LRCH1, ESR1, OPG, TNA,
COX2, CD36, NCOR2, TNFAIP6,ASPN, CALM1. Genotype fre-
quencies at a total of 37 polymorphisms in the above genes were
compared between cases and controls separately by gender. We
fitted a multivariate model with estimated knee OA risk as a func-
tion of all the polymorphisms in genes which were involved in this
population as well as in independent studies. A new "OA genetic
risk" variable was derived using the best fit in women with a
minimum value of 0 and a maximum of 6. This same model was
then tested in men.
Results: We found that SNPs in 12 genes were significantly
associated with disease susceptibility in women in our cohort
and SNPs in 8 of the genes were associated in men. The
proportion of individuals affected with knee OA in the case-
control study indicated that a much higher prediction of OA
risk can be achieved by combining several genes which have
consistently shown to be involved in OA genetic susceptibility.
In particular we found that comparing women with a high "OA
genetic risk" (>4) to those with low genetic risk (<2.5) resulted
in an odds ratio of 11.15 (95%CI 5.1, 24.6p< 1 x 10-16). In men
the same comparison resulted in OR= 4.27 (95%CI 2.4, 7.7 p<1
x 10-7).
Conclusions: These data indicate that using a multiple gene
approach, a higher genetic risk prediction is achievable in women
with OA.
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RECOMIBINANT HUMAN CARTILAGE-DERIVED
RETINOIC ACID SENSITIVE PROTEIN (CD-RAP) -
A NOVEL TREATMENT OPTION FOR OSTEOARTHRITIS
S.D. Pippig, K. Hellerbrand, C. Dony
Scil Technology, Martinsried, Germany
Purpose: Osteoarthritis is a significant worldwide health problem
owing to the progressive and debilitating nature of the condition,
which results in high morbidity and a marked decrease in the
quality of life. It is the most common articular disorder in humans.
New treatment options for this disease are required because
currently no consistently working treatments are available.
Cartilage-derived retinoic acid sensitive protein (CD-RAP) is a
highly specific marker for chondroid differentiation and has been
shown in in vitro and in vivo assays to be a crucial determinant
in cartilage differentiation and maintenance. It was evaluated
whether CD-RAP alleviates or prevents cartilage degradation in
an animal model of osteoarthritis.
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Methods: 24 skeletally mature New Zealand White rabbits un-
derwent anterior cruciate ligament transection. 6 additional sham
operated animals were used as controls. 10 days after the
surgery the transected animals received an intraarticular injec-
tion of CD-RAP encapsulated in liposomes or liposomes alone
as vehicle control. Three different dose levels of CD-RAP were
tested. Thereafter the animals were injected every 10 days until
the end of the 9-week treatment period. The animals were anal-
ysed macroscopically, radiologically, and histologically. To score
the radiological and histological data, the Kellgren and a modified
Mankin score, respectively, were used.
Results: CD-RAP treatment resulted in reduced osteophyte for-
mation and reduced joint space narrowing. This effect was signif-
icant as shown by the radiological scoring There was a trend to-
wards middle and high dose CD-RAP being more efficacious than
the low dose group but this was not statistically significant. The
histological evaluation by the modified Mankin score, which eval-
uated cartilage structure, cells, matrix (safranin-O), and tidemark
integrity, confirmed the radiological results. The average scores
for sham, vehicle, and treatments groups (low, mid and high dose
CD-RAP) were 1.12±1.19, 7.28±2.19, 7.22±2.69, 4.08±0.8,
4.47±1.93. Both middle and high dose CD-RAP groups showed
a significant improvement over the vehicle group. Looking at the
individual parameters, CD-RAP appeared to impact structural
integrity as well as matrix content.
Conclusions: These data suggest that treatment with the carti-
lage specific protein CD-RAP may be a new therapeutic option
for osteoarthritis patients. Next steps will include the long-term
evaluation of liposome-encapsulated CD-RAP in a large animal
model.
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MODULATION OF COLLAGEN NETWORK FORMATION
TO IMPROVE FUNCTIONAL PROPERTIES IN CARTILAGE
REGENERATION
Y.M. Jenniskens1, W. Koevoet1, A.C. De Bart2, J.A. Verhaar1,
H. Weinans1, G.J. van Osch1, J. DeGroot2
1Erasmus MC, University Medical Center, Rotterdam, The
Netherlands, 2TNO Quality of Life, Leiden, The Netherlands
Purpose: Osteoarthritis is characterized by the progressive de-
struction of articular cartilage. Damage to the collagen network
is often considered irreversible, whereas proteoglycan loss is
reversible. Understanding mechanisms of repair of the collagen
network is therefore key for functional repair of cartilage. The
present study was designed to test whether collagen synthesis
and subsequent crosslinking could be influenced such that a
functional collagen network is formed.
Methods: Bovine articular chondrocytes were cultured in algi-
nate beads for 5 weeks in the presence or absence of the lysyl
oxidase inhibitor BAPN (0.25 mM) followed by 5 weeks without
BAPN (+/- or -/-). Collagen deposition and amout of crosslinks
(HPLC) and gene expression of collagen type 1 and 2 and SOX9
(RT-QPCR) were measured. Susceptibility of the extracellular
matrix to in vitro degradation by MMP-1 was examined after 70
days of culture by overnight incubating 4 alginate beads with
100nM MMP-1. Alginate constructs of 3 mm thick and 6 mm in
diameter were used to determine the equilibrium modulus and
de secant modulus by unconfined compression. Here, an extra
control was added to examine the effect of no crosslinks after 10
weeks of culture with BAPN (+/+).
Results: Complete inhibition of collagen crosslinking for 5 weeks
by BAPN increased the collagen deposition 1.8 times, with a
concomitant increase in tissue stiffness (the equilibrium mod-
ulus increased from 451 Pa to 879 Pa), despite the absence
of crosslinks in the BAPN condition. When after 10 weeks the
amount of collagen is further increased, crosslinks also seem to
be important in improving the stiffness of the matrix. From week 8
onwards, i.e. 3 weeks after removal of the crosslink inhibitor, the
crosslinks returned approaching the level of the control condition
at week 10. With equal amount of crosslinks (-/- and +/-) the
equilibrium modulus is higher when more collagen was present.
However, the total absence of collagen crosslinks together with
more collagen resulted in a lower secant modulus in the +/+ con-
dition, indicating a higher permeability of the matrix. Incubation
of 10-week-old beads in buffer with collagenase MMP-1, lead
to a 2.5 fold increase of collagen release in the supernatant in
the condition without crosslinks (+/+) than in the two conditions
with crosslinks (-/- and +/-). SOX9 expression was not influenced
by addition of BAPN whereas the COL2/COL1 ratio was higher,
indicating that inhibition of crosslinks results in more collagen
without affecting chondrocyte phenotype significantly.
Conclusions: Modulation of the amount of crosslinking and
subsequently collagen deposition, during cartilage tissue regen-
eration has an effect on the functional properties of the construct.
After 5 weeks, more collagen alone led to an increase of stiffness
of the matrix. However, when more collagen was deposited after
10 weeks, crosslinks were also needed to improve matrix stiff-
ness. The quality of the matrix indicated by MMP-1 degradation
susceptibility is not influenced by the transient crosslink inhibi-
tion. These data suggest that modulation of the collagen network
may be a feasible approach to induce cartilage regeneration.
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CARTILAGE ENGINEERING AND REPAIR:
CONTRIBUTION OF HUMAN GLYCOSYLTRANSFERASES
IN THE BIOSYNTHESIS OF MATRIX
GLYCOSAMINOGLYCANS
J. Magdalou, S. Gulberti, M. Fondeur-Gelinotte, L. Barré,
V. Lattard, C. Bui, P. Netter, N. Venkatesan, S. Fournel-Gigleux,
M. Ouzzine
UMR 7561 CNRS-Université Henri Poincaré Nancy 1,
Vandoeuvre-lès-Nancy, France
Purpose: Osteoarthritis is the most prevalent chronic human
disease characterised by a deterioration of cartilage. Despite
its important socio-economical impact, there is, until now, no
satisfactory way to treat the disease. Symptomatic treatment
with antalgics or anti-inflammatory drugs does not stop the
progression of cartilage degeneration, and often presents side-
effects, which limit their chronic use. Our goal is to design new
therapeutic approaches, keeping in mind that cartilage is one of
the rare human tissues which is unable to regenerate. The loss
of matrix components, especially glycosaminoglycans (GAG), is
an early event of cartilage damage.
Methods: An innovative strategy of cartilage bioengineering con-
sists in overexpression by gene transfer, of glycosyltransferases
able to stimulate the anabolic activity of chondrocytes, in or-
der to promote cartilage repair. In that context, the research of
our group is mainly devoted to the identification, cloning and
structural characterisation of key-glycosyltransferases involved
in the biosynthesis of GAG of the cartilage matrix. The work
has been especially focused on the human galactose β 1,3-
glucuronosyltransferase-I (GlcAT-I) which is involved in the final
step of the biosynthesis of the common GAG-protein tetrasac-
charidic linkage sequence, GlcA β1-3Gal β1-3Gal β1-4Xyl-O-.
Results: We have shown that any variation of the GlcAT-I activity
in chondrocytes or cartilage explants, either upon overexpres-
sion, or, in contrast, by repression with antisense RNA, could
increase, or decrease the GAG content in cartilage, respec-
tively. Interestingly, overexpression of this enzyme was able to
completely counteract the proinflammatory cytokine, interleukine
1β-induced depletion of GAG. The neosynthesised GAG were
qualitatively similar to those present in the original cartilage ma-
